MYO10 and non-small cell lung carcinoma: We found that the expression of MYO10 was commonly elevated in both aggressive sub-cell lines compared with their parental cells, further analysis demonstrated a significant high levels of MYO10 in human NSCLC tissues with lymphatic metastasis (Figure 4), implying the potential association of MYO10 with NSCLC metastasis.